近日，由赵大海、林海江、张智若为共同作者，在SSCI、SCI双检索期刊《Risk Management and Healthcare Policy》发表了一篇题为“Evidence-Based Framework and Implementation of China’s Strategy in Combating COVID-19”（基于实证依据的中国抗击新冠疫情的策略框架和实施）的论文。
Dahai Zhao, Haijiang Lin, and ZhiRuo Zhang Jointly Published a Paper on The Strategic of China's Successful Fight against COVID-19 in SSCI Journal
Recently, Dahai Zhao, Haijiang Lin and Zhiruo Zhang as co-authors, have published a paper entitled "Evidence-Based Framework and Implementation of China’s Strategy in Combating COVID-19" (a strategy framework and implementation based on empirical evidence for combating COVID-19 in China) in Risk Management and Healthcare Policy, a double-indexed journal of SSCI and SCI.
Based on the whole process of fighting COVID-19 in a prefecture-level city and relevant survey data of all confirmed COVID-19 patients, this paper fully reveals the mystery of why China has controlled the COVID-19 outbreak in less than two months. At the same time, this paper further demonstrates the necessity, efficiency and feasibility of China's successful strategy to combat COVID-19. The strategic framework of China's fight against COVID-19 has provided important policy lessons and references for other countries in the fight against COVID-19, as well as the confidence of mankind to defeat COVID-19.
This paper is the fourth SCI/SSCI paper on COVID-19 prevention and control published by Shanghai Jiao Tong University-Yale University Joint Center for Health Policy. Haijiang Lin is deputy director and chief physician of the Taizhou Center for Disease Control and Prevention in Zhejiang Province, and Dahai Zhao and Zhiruo Zhang are researchers at the Shanghai Jiaotong University-Yale University Joint Research Center for Health Policy.